M EN3 (Eprosartan mesylate 600 mg)

Pill imprint M EN3 has been identified as Eprosartan mesylate 600 mg.

Eprosartan is used in the treatment of high blood pressure and belongs to the drug class angiotensin receptor blockers. There is positive evidence of human fetal risk during pregnancy. Eprosartan 600 mg is not a controlled substance under the Controlled Substance Act (CSA).

Eprosartan mesylate

Imprint:

M EN3

Strength:

600 mg

Color:

White

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Angiotensin receptor blockers

Pregnancy Category:

D - Positive evidence of risk

CSA Schedule:

Not a controlled drug

Manufacturer:

Matrix Laboratories Limited

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.